logo
Search by title of article or author name:

Volume 28, Supplement 1

PRESENTATION
1 – Message from the organizing committee.

ORAL
2 – MAMMOGRAPHY FOR BREAST CANCER SCREENING IN BRAZIL: A CURRENT PROFILE.
Karla O. Elesbão, Felipe Z. Pereira, Victória O. Prados, Pedro Paulo D. Soares, Maria Angélica E. Franco, Fabiane A. Carvalho.

3 – HIGH RISK FOR CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL BREAST CANCER SURVIVORS.
Daniel A. B. Buttros , Mauro T. Branco , Benedito S. A. Filho , Jorge Nahás-Neto , Eliana A. P. Nahás.

4 – EPIDEMIOLOGICAL PROFILE OF BREAST CANCER IN MEN IN BRAZIL BETWEEN 2008 AND 2018.
Felipe Z. Pereira, Karla O. Elesbão, Victória O. Prados, Fabiane A. Carvalho.

5 – PERI-LYMPH NODAL PATHOLOGICAL FIBROSIS AND AXILLARY SURGICAL IMPAIRMENT AFTER 14G PERCUTANEOUS FRAGMENT BIOPSY OF SENTINEL LYMPH NODE DETECTED WITH CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN EARLY BREAST CANCER PATIENTS.
Nicoli Serquiz, Carlos A. Menossi, Natalie R. Almeida, Gabrielle Baccarin, Geisilene R. P. Silva, Luciano Moro, Sophie Derchain, Rodrigo M. Jales.

6 – CLINICAL QUALITY CONTROL OF MAMMOGRAMS EVALUATED IN A BRAZILIAN TERTIARY HOSPITAL.
Leonardo R. Soares, Rosemar M. S. Rahal, Victória C. J. Queiroz, Erika C. Aquino, Rosangela S. Correa, Danielle C. N. Rodrigues, Ruffo Freitas-Junior.

7 – LATE RESULTS OF REGIONAL BREAST CANCER SCREENING PROGRAM PERFORMED IN THE INTERIOR OF SÃO PAULO STATE, BRAZIL.
Idam Oliveira-Junior, Edmundo C. Mauad, Bruno O. Fonseca, Anapaula H.U. Watanabe, René A.C.Vieira Barretos Câncer Hospital – Barretos (SP), Brazil.

8 – ONCOPLASTIC SURGERY IN THE CONSERVATIVE TREATMENT OF THE LOCALLY ADVANCED BREAST CANCER: A SISTEMATIC REVIEW.
Daniela C.C.C. E. Ribeiro, Cláudia A. A. Góes, Naiana S. C.Andrade, Lucas G. Ramos, Luiz Fernando J. Ribeiro, Régis R. Paulinelli.

9 – ANALYSIS OF BOOST VOLUME DEFINITION IN RADIATION THERAPY FOR CONSERVATIVE BREAST SURGERY.
Thiago Brasileiro de Freitas, Kennya Medeiros Lopes de Barros Lima, Heloísa de Andrade Carvalho, Alexandre Siqueira Franco Fonseca, Alexandre Mendonça Munhoz, José Roberto Filassi, Silvia R. Stuart, Gustavo Nader Marta.

10 – EXPRESSION OF β-CATENIN AND E-CADHERIN IN BREAST DUCTAL CARCINOMA IN SITU AND THEIR ASSOCIATION WITH SURVIVAL: FOLLOW UP OF 9.0 YEARS.
Giuliano M. Duarte, Helena Slongo, Marcelo L. Montenegro, Fernando Tocchet, Juliana Espinola, Fernando Augusto Soares, Priscila Marshall, Geisilene R. P. Silva.

11 – PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y).
Laura Testa, Ruffo Freitas-Junior, Sergio V Serrano, Roberto J Arai, Marina C Zorzetto, Oren Maletz, Max S Mano, Paulo M Hoff.

12 – TRANSCRIPTION EXPRESSION OF IL-6 AND IL-1β GENES AND ITS RELATION WITH THE EFFICACY OF CHEMOTHERAPY IN WOMEN WITH BREAST CANCER.
Jéssica P. Oliveira, Isis D. D. Custódio, Alinne T. F. Câmara, Izabella C. C. Ferreira, Marceila A. Fuzissaki, Thaise G. de Araújo, Luiz R. Goulart, Yara C. P. Maia.

13 – ASSOCIATION OF ONCOGENE RAC 1 WITH HER-2 TUMORS AND WITH AGGRESSIVITY OF TRIPLE NEGATIVE TUMORS.
Maria Amelia Carlos Souto Maior Borba, Joana Darc Rosendo dos Santos, Nancy Cristina Ferraz de Lucena Ferreira, Darley de Lima Ferreira Filho, Glauber Moreira Leitão, Danyelly Bruneska Gondim Martins.

14 – TWIST1 KNOCKDOWN ELUCIDATES THE REGULATION OF TH17-LIKE RESPONSE IN HER2 BREAST CANCER SUBTYPE.
Bruno R. B. Pires, Renata Binato, Gerson M. Ferreira, Barbara Du Rocher, Stephany Corrêa, Daniel Bulzico, Eliana Abdelhay.

15 – ANALYSIS OF PEAK TORQUE OF WOMEN TREATMENT CHEMOTHERAPY WITH APPARENTLY HEALTHY WOMEN.
Vitor Marques, Rafael Alves, Thaynã Guimarães, Rafael Moraes, Weder Silva, Danielly Dias, Camila Seguro, Carlos Vieira.

16 – ANALYSIS OF A SYNONYMOUS SINGLE NUCLEOTIDE VARIANT IN PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA GENE IN TRIPLE NEGATIVE BREAST CANCER .
Joana D. R. Santos, Nancy C. F. L. Ferreira, Darley L. F. Filho, Cintia R. C. Rocha, Carlos H. M. Castelletti, José L. L. Filho1, Danyelly B. G. Martins.

COMMENTED POSTER

17 – INVESTMENT OF THE UNIFIED HEALTH SYSTEM IN SCREENING MAMMOGRAPHY IN BRAZIL, 2008–2017.
Danielle Cristina Netto Rodrigues, Ruffo Freitas-Junior, Rosemar Macedo Sousa Rahal, Luiz Paulo da Silveira Corrêa, Rosangela da Silveira Corrêa.

18 – RETURN TO WORK ITS IMPACT ON THE QUALITY OF LIFE OF BRAZILIAN BREAST CANCER PATIENTS.
Isabela C. F. Colombino, Idam Oliveira-Junior, Fabiola C. B. Silva, Jonathas J. Silva, Almir J. Sarri, Rene A. C. Vieira.

19 – AGE OF DIAGNOSIS AND BODY MASS INDEX IN BREAST CANCER PATIENTS: ANALYSIS OF A BRAZILIAN REFERENCE CENTRE.
Luiz Henrique Gebrim, André Mattar, Jorge Y. Shida, Roberto Hegg, Ana Luiza A. Faria, Felipe A. Cavagna.

20 – MICRORNAS AS BIOMARKERS FOR BREAST CANCER PROGNOSIS: A SYSTEMATIC REVIEW.
Bárbara A.S. Soares, Cesar A.S.T. Vilanova-Costa, Deidimar C.B. Abreu, Vera A. Saddi.

21 – EFFECTS OF [10]-GINGEROL IN COMBINATION WITH DOXORUBICIN ON TRIPLE NEGATIVE BREAST CANCER IN VITRO AND IN VIVO.
Ana Carolina B.M. Martin, Rebeka Tomasin, Marina de Araújo Naves, Angélica Graminha, Liany Luna-Dulcey, Ramon H.G. Teles, Márcia Regina Cominetti1.

22 – ANALYSIS OF POLYMORPHISMS IN THE TP53 GENE IN PATIENTS WITH CLINICAL DIAGNOSIS FOR HEREDITARY BREAST CANCER .
Paula F. F. Silva, Rebeca M. Goveia1, Thais B. Teixeira, Hugo Deleon, Gabrielly R. Abrantes1, Kézia A. Delmond, Aliny P. de Lima, Jeffter R. Silva, Elisângela de P. S. Lacerda.

23 – COMPARISSON BETWEEN MORPHOLOGICAL ASPECTS ON THE MAMMARY ULTRASSONOGRAPHY OF BREAST MALIGNANT NEOPLASIES AND THE IMMUNOHISTOCHEMISTRY PROFILE OF THESE TUMORS.
Alexandre V. de Andrade, Ricardo M. Neto, Renato S. Discini, Luis C. F. de Almeida, Juliana A. Fermolli, Gabriela B. C. Silva.

24 – TNM8 BREAST CANCER CALCULATOR: A TOOL FOR BREAST CANCER STAGING ACCORDING TO THE TNM 8TH EDITION.
Wesley Pereira Andrade.

25 – PROSPECTIVE STUDY OF POSTOPERATIVE WHOLE BREAST RADIOTHERAPY FOR PATIENTS WITH LARGE AND PENDULOUS BREAST: A CLINICAL AND DOSIMETRIC COMPARISONS BETWEEN SUPINE AND PRONE POSITIONS.
Izabela Lourenço Silva Fernandes, José Maria Fernandes Júnior, Marcelo Luvizotto Alcântara de Pádua, Marília Ferreira Andrade, Nayara Ferreira Cunha, Marcela Carrijo Setti, Fredstone Rodrigues da Cunha.

26 – HAND2 AND ER EXPRESSION IN BREAST CANCER.
Quiti. Lopes, Ernesto de Paula Guedes Neto, José Luiz Pedrini, Ricardo Francalacci Savaris.

27 – EFFECTIVENESS OF DIFFERENT ACCELERATED PARTIAL BREAST IRRADIATION TECHNIQUES FOR THE TREATMENT OF BREAST CANCER PATIENTS: SYSTEMATIC REVIEW USING INDIRECT COMPARISONS OF RANDOMIZED CLINICAL TRIALS [EFFECTIVENESS OF DIFFERENT APBI TECHNIQUES].
Gustavo Nader Marta, Gustavo José Martiniano Porfirio, Ana Luiza Cabrera Martimbianco, Jessica Barrett, José Luiz Barbosa Bevilacqua, Philip Poortmans, Rachel Riera.

28 – THE ROLE OF PALLIATIVE RADIOTHERAPY IN LOCALLY ADVANCED BREAST CANCER REFRACTORY TO NEOADJUVANT CHEMOTHERAPY AND UNRESECTABLE.
Ana Flávia de Paula Guerra Campedelli, Nilceana Aires Maya Freitas, Thais Franco Simionatto, Nathalya Ala Yagi, Jean Teixeira de Paiva, Carolina Martinelli Bezerril.

29 – THE IMPACT OF RADIODERMATITIS IN QUALITY OF LIFE OF PATIENTS WITH BREAST CANCER DURING TREATMENT: A PROSPECTIVE LONGITUDINAL STUDY.
Marceila A. Fuzissaki, Carlos E. Paiva, Marco A. Oliveira, Mariana T. M. Lima, Paula P. L. Canto, Yara C. P. Maia.

30 – A PROTECTIVE EFFECT OF MORNING RADIOTHERAPY ON SKIN TOXICITY IN PATIENTS WITH BREAST CANCER.
Marceila A. Fuzissaki, Carlos E. Paiva, Marco A. Oliveira, Mariana T. M. Lima, Paula P. L. Canto, Yara C. P. Maia.

31 – EXPRESSION OF PRO- AND ANTIANGIOGENIC VEGF-A ISOFORMS AND SPLICING REGULATORY FACTORS IN BREAST CANCER.
Rodrigo Castro, Beatriz P. Bertelli, Patrícia M. Biselli-Chicote, Dalísio S. Neto, José Luis E. Francisco, Érika C. Pavarino, Eny M. Goloni-Bertollo.

E-POSTER

32 – PHARMACOKINETIC MODEL FOR QUANTITATIVE EVALUATION OF THE EPR EFFECT ON ALBUMIN-BASED NANOCARRIERS.
Ailton A. Sousa-Junior, Gustavo C. P. Leite1, Nicholas Zufelato, Francyelli Mello-Andrade, Wanessa C. Pires, Elisângela P. Silveira-Lacerda, Andris F. Bakuzis.

33 – THE RADIATION THERAPY IN OCCULT PRIMARY BREAST CANCER: CASE SERIES.
Ana Flávia de Paula Guerra Campedelli1, Nilceana Maya Aires Freitas, Thais Franco Simionatto1, Nathalya Ala Yagi, Jean Teixeira de Paiva, Carolina Martinelli Bezerril.

34 – IR-780 BASED-NANOPARTICLE CYTOTOXIC EFFECT ON MURINE BREAST CANCER CELLS (EHRLICH).
André Luiz Silva Oliveira, Nicholas Zufelato, Letícia Reis Silva, Andris Figueiroa Bakuzis, Elisângela de Paula Silveira-Lacerda.

35 – TIME BETWEEN DIAGNOSIS AND BEGIN OF THE TREATMENT IN A PUBLIC BRAZILIAN HOSPITAL IN SÃO PAULO.
André Mattar, Jorge Y. Shida, Roberto Hegg, Felipe A. Cavagna, Ana Luiza A. Faria, Luiz H. Gebrim.

36 – THE VALUE OF STEREOTACTIC VACUUM-ASSISTED BIOPSY IN THE INVESTIGATION OF MICROCALCIFICATIONS IN 1354 PATIENTS IN PUBLIC BRAZILIAN HOSPITAL.
Andressa G. Amorim, Marcellus N. M. Ramos, André Mattar, Jorge Y. Shida, Luiz H. Gebrim.

37 – PYODERMA GANGRENOSUM: REPORT OF A CASE INVOLVING THE BREAST.
Andressa G. Amorim, Marcellus N. M. Ramos, Felipe A. Cavagna, Maria I. B. A. C. Sawada, Alexandre S. Melitto, André Mattar, Jorge Y. Shida, Luiz H. Gebrim.

38 – STAGE AND IMMUNOHISTOCHEMISTRY OF EIGHT THOUSAND CASES OF BREAST CANCER TREATED IN A BRAZILIAN REFERENCE CENTRE.
Luiz Henrique Gebrim, André Mattar, Jorge Yoshinori Shida, Roberto Hegg.

39 – ANALYSIS OF 41 PATIENTS WHO UNDERWENT ADENOMASTECTOMY AFTER A BREAST CANCER DIAGNOSIS IN A PUBLIC BRAZILIAN HOSPITAL.
Andressa G. Amorim, Marcellus N. M. Ramos, André Mattar, Jorge Y. Shida, Luiz H. Gebrim.

40 – BIOMARKER EXPRESSION IN BREAST CANCER. CORRELATIONS WITH OUTCOME FOLLOWING NEOADJUVANT CHEMOTHERAPY.
Augusto Ribeiro Gabriel, Ruffo Freitas-Junior.

41 – OBESITY INCREASES THE RISK OF BREAST CANCER IN POSTMENOPAUSAL WOMEN?
Carolina R. Mendonça, Magno B. Cirqueira, Jalsi T. Arruda, Nilza N. Guimarães, Erika A. Silveira, Waldemar N. do Amaral.

42 – BRCA1 AND MICRORNAS 7, 10B, 205AB, 218A EXPRESSION AS PROGNOSTIC MARKERS IN PRIMARY BREAST CANCERS – A RETROSPECTIVE COHORT STUDY.
Cesar A. S. T. Vilanova-Costa, Jéssica E. P. Ramos, Juliana F. Paes, Daniel R. Bastos, Nathália A. Nogueira, Silvia H. Rabelo-Santos, Raphael B. Parmigiani, Vera A. Saddi.

43 – PROSTHESIS EXPOSURE MANAGEMENT AFTER IMMEDIATE BREAST RECONSTRUCTION.
Cícero de Andrade Urban, Rafael Amin Menezes Hassan, Rubens Silveira de Lima.

44 – AN TYROSINE KINASE RECEPTOR AS PROMISING THERAPEUTIC TARGET FOR TRIPLE NEGATIVE BREAST CANCER.
Joana D. R. Santos, Maria F. S. Cardoso, Carlos H. M. Castelletti, Nancy C. F. L. Ferreira, Darley L. F. Filho, José L. L. Filho, Danyelly B. G. Martins.

45 – EVALUATION OF THE FALSE NEGATIVE RATE IN THE EXAMINATION OF FREEZING OF THE SENTINEL LYMPH NODE IN HBL – RECIFE (PE).
Ana Flavia Morais Leda, Darley de Lima Ferreira Filho, Nancy Cristina Ferraz de Lucena Ferreira.

46 – BREAST CANCER IN AN 18-YEAR-OLD PATIENT: A CASE REPORT.
Maria Letícia Moraes, Eduardo Resende Sousa e Silva, Laura Viana de Lima, Carla Paulinelli Seba, Isabela Vieira Bastos, Ana Paula Teixeira Leite, João Emanuel Meireles Gonçalves, Renata Pereira Fontoura.

47 – SYNTHETIC CHALCONES CYTOTOXIC ACTIVITY ON EHRLICH ASCITIC TUMOR CELLS (MURINE BREAST CANCER).
Eliane B. Nunes, Aline Bernardes, Caridad Noda-Perez, Stanislau P. Cardozo, Hugo D. Silva, Ingrid O. Travassos, Paula F. F. Silva, Elisângela P. Silveira-Lacerda.

48 – PROGNOSTIC EVALUATION OF PATIENTS WITH TRIPLE NEGATIVE IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY.
Fábio F. O. Rodrigues, Etiénne A. Bastos, Laís A. Inaba, Eveline A. Silva, Rodrigo M. Silva, Carlos E. Fristachi.

49 – IMPACT OF THE NEW STAGING TNM AJCC ON THE EVALUATION OF PATIENTS WITH BREAST CANCER.
Fábio F. O. Rodrigues, Etiénne A. Bastos, Laís A. Inaba, Eveline A. Silva, Rodrigo M. Silva, Carlos E. Fristachi.

50 – BIOLOGICAL BEHAVIOR OF BREAST CARCINOMA IN SITU FROM JANUARY 2006 TO DECEMBER 2012.
Fábio F. O. Rodrigues, Etiénne A. Bastos, Laís A. Inaba, Eveline A. Silva, Rodrigo M. Silva, Carlos E. Fristachi.

51 – PROGNOSTIC EVALUATION OF PATIENTS WITH LUMINAL B IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FROM 2006 TO 2012.
Fábio F. O. Rodrigues, Etiénne A. Bastos, Laís A. Inaba, Eveline A. Silva, Rodrigo M. Silva, Carlos E. Fristachi.

52 – EVALUATION OF PATIENTS WITH INVASIVE BREAST CARCINOMA SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FORM 2006 TO 2012.
Fábio F. O. Rodrigues, Etiénne A. Bastos, Laís A. Inaba, Eveline A. Silva, Rodrigo M. Silva, Carlos E. Fristachi.

53 – COMPARATIVE ANALYSIS OF THE USE OF FINE NEEDLE ASPIRATION IN THE DIFFERENTIAL DIAGNOSIS OF BREAST NODES IN THE STATE OF GOIÁS.
Fernando C. Silva, Edison B. L. B. Junior, Cassiano S. Coutinho, Rayssa F. Silva, Rayssa O. Glória, Fabiana C. Q. S. Anjos, Vantuir J. D. Mota, Priscila F. Barbosa.

54 – RUTHENIUM (II)/AMINO ACID/DIPHOSPHINE COMPLEXES AS APOPTOSIS INDUCERS IN BREAST CANCER CELLS AND THEIR TOXIC EFFECTS IN ANIMAL MODELS.
Francyelli Mello-Andrade, Clever G. Cardoso, Paulo Melo-Reis, Cesar Grisólia, Carlos Castro, Carlos Menck, Alzir A. Batista, Elisângela Silveira-Lacerda.

55 – A RARE CASE OF METASTATIC MELANOMA IN THE BREAST.
Aline R. Nunes, Célio S. R. Vidal, Délio M. Conde, Erika P. S. Silva, Flávia V. Cabero, Gustavo L. Q. Lima, Kauana C. S. Nascimento, Rogério B. Ferreira.

56 – EPIDEMIOLOGICAL ANALYSIS OF GRANULOMATOUS MASTITIS AT THE MASTOLOGY SERVICE AT HOSPITAL MATERNO INFANTIL DE GOIÂNIA.
Aline R. Nunes, Célio S. R. Vidal, Délio M. Conde, Erika P. S. Silva, Flávia V. Cabero, Gustavo L. Q. Lima, Rogério B. Ferreira, Paola F. Freitas.

57 – PATTERNS OF POST-OPERATIVE IRRADIATION IN BREAST CANCER PATIENTS SUBMITTED TO NEOADJUVANT CHEMOTHERAPY.
Kennya Medeiros L. de B. Lima, Thiago B. de Freitas, Allan A. Lima Pereira, Saulo Brito Silva, Heloisa de Andrade Carvalho, José R. Filassi, Max S. Mano, Gustavo Nader Marta.

58 – DOES THE ADDITION OF THE NEW PROGNOSTIC BIOMARKERS ON EIGHTH EDITION OF AJCC CHANGE BREAST CARCINOMAS STAGING?
Jéssica E. P. Ramos, Cesar A. S. T. Vilanova-Costa, Juliana F. Paes, Vera A. Saddi.

59 – LATISSIMUS DORSI MUSCULOCUTANEOUS FLAP RECOSNTRUCTION AFTER NIPPLE SPARING MASTECTOMY COMPLICATION: CASE REPORT.
Jorge V Biazus, Andrea Damin, José A Cavalheiro, Angela Zucatto, Rodrigo Cericatto, Marcia P. Melo, Anita S. Cassiano, Murilo L. Brazan.

60 – QUALITY OF LIFE IN PATIENTS WITH LYMPHEDEMA SUBMITTED TO SURGICAL TREATMENT FOR BREAST CÂNCER ATTENDED AT THE PHYSIOTHERAPY AMBULATORY OF A REFERENCE HOSPITAL OF THE FEDERAL DISTRICT.
Kalléria W.C. Borges, Laércio L. Luz.

61 – PREVALENCE OF BREAST ABNORMALITIES FOUND IN ULTRASSOUND.
Laís L. Neves, Fernanda G. Filardi, Dânisa S. Carrijo, Julia B. Gomes, Milena V. M. Moreira, Felipe Augusto A. Carvalho, Raphael Costa Lima, Waldemar Naves Amaral.

62 – MALIGNANT PHYLLODES TUMOR OF THE BREAST: REPORT OF TWO CASES AND A RARE ASSOCIATION.
Leandro G. Oliveira, Barbara A. Barbosa, Elaine X. Machado, Thamires S. Lopes, Ana Cláudia G. Lima, Alexandre M. X. de Jesus, Sebastião A. Pinto, Juarez A. de Sousa.

63 – PATHOLOGICAL FEATURES AND GENETIC TESTING AMONG BREAST CANCER YOUNG WOMEN: A SINGLE-INSTITUTION EXPERIENCE.
Leandro G. Oliveira, Ana C. G. Lima, Danilo A. Gusmão, Deidimar C. B. Abreu, Frank L. B. Rodrigues, Alexandre Marchiori, Juarez A. Sousa, Rosemar M. S. Rahal.

64 – MOLECULAR ANALYSIS OF TRANSLOCATIONS ASSOCIATED WITH EWING’S SARCOMA IN THE DIFFERENTIAL DIAGNOSIS OF UNDIFFERENTIATED AND UNCLASSIFIED SARCOMAS.
Leonardo R. Soares, Marise A. R. Moreira, Paula O. C. Queiroz, Hugo A. Bayeh, Izabela C. S. Albuquerque, Miguel A. C. Coutinho, Débora F. Rodrigues1, Ruffo Freitas-Junior.

65 – EPIDEMIOLOGIC ANALYSIS OF MAMMOGRAPHY IN WOMEN WITH LESS THAN 45 YEARS OF AGE IN GOIÁS BETWEEN 2010–2013.
Ana C. L. Caixeta, Bruna O. Andrade, Lucas de S. Steinmetz, Lucas N. Silva, Lucas V. Peixoto, Matheus L. T. Costa, Júlia J. Caetano, Vitória N. Macedo.

66 – PREVALENCE OF TYPES OF BENIGN BREAST LESIONS, BY AGE GROUP, IN GOIÁS.
Ana C. L. Caixeta, Bruna O. Andrade, Lucas de S. Steinmetz, Lucas N. Silva, Lucas V. Peixoto, Matheus L. T. Costa, Júlia J. Caetano, Vitória N. Macedo.

67 – IMPACT OF TAMS IN TUMOUR MICROENVIRONMENT AS PROGNOSTIC MARKERS IN BREAST CANCER.
Luciana V Q Labre, Vera A Saddi2, Aline C Batista, Juliana F Paes, Jessica E P Ramos, Cesar A S T Vilanova-Costa, Erika C Aquino, Silvia H Rabelo-Santos.

68 – M2-TYPE MACROPHAGES IN TUMOUR MICROENVIRONMENT AS PROGNOSTIC MARKERS IN WOMEN WITH BREAST CANCER.
Luciana V Q Labre, Vera A Saddi, Megmar A S Carneiro, Aline C Batista, Diego A C Arantes, Jessica E P Ramos, Erika C Aquino, Silvia H Rabelo-Santos.

69 – IN VIVO IMAGING USING BIOLUMINESCENCE FOR EVALUATION OF ANTITUMORAL EFFICACY IN A BREAST CANCER MODEL.
Raquel S. Faria, Luiza I. de Lima, Marina S. Franco, Marjorie C. Roque, Mônica C. Oliveira, Ricardo B. Azevedo, João Paulo F. Longo.

70 – PAIN IN WOMEN WITH BREAST CANCER.
Magno B. Cirqueira, Carolina R. de Mendonça, Leonardo R. Soares, Marise A. R. Moreira, Ruffo Freitas-Júnior.

71 – IS THERE AGREEMENT BETWEEN EVALUATORS THAT USED TWO SCORING SYSTEMS TO MEASURE ACUTE RADIATION DERMATITIS?
Marceila A. Fuzissaki, Carlos E. Paiva, Marcelo A. Maia, Mariana T. M. Lima, Paula P. L. Canto, Yara C. P. Maia.

72 – PHYSICAL ACTIVITY AND HEALTH RELATED QUALITY OF LIFE OF BREAST CANCER WOMEN SUBMITTED TO NEOADJUVANT CHEMOTHERAPY.
Julia de M. R. Medina, Suzana S. de Aguiar, Luiz Claudio S. Thuler, Marcelo Adeodato Bello, Anke Bergmann.

73 – IMPACT OF NUMBER OF POSITIVE LYMPH NODES AND LYMPH NODE RATIO ON SURVIVAL OF WOMEN WITH NODE-POSITIVE BREAST CANCER.
Fabiana Tonellotto, Anke Bergmann, Karende Souza Abrahão, Suzana Sales de Aguiar, Marcelo Adeodato Bello, Luiz Claudio Santos Thuler.

74 – SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN WOMEN WITH BREAST CANCER: CLINICAL PROFILE AND PROGNOSIS.
Marcelo Bello, Anke Bergmann, Marcelo Barbosa, Suzana Aguiar, Fabiana Tonellotto, Sergio Monteiro, Patricia Juca, Luiz Claudio Santos Thuler.

75 – SURVIVAL IN PATIENTS WITH STAGE IV HER2 POSITIVE BREAST CANCER.
Marcelo A. Bello, Marcelo M. Barbosa, Marcela E. Carvalho, Sergio Monteiro, Patricia Juca, Anke Bergmann.

76 – PROFILE OF MAMMOGRAPHIES REALIZATION IN BRAZIL BETWEEN 2013 AND 2014.
Lara C. R. Alvarenga, Luís M. M. Medeiros, Mateus F. O. Vilela, Bráulio B. Rodrigues, Isadora G. C. K. Severino, Júlia R. Moraes, Mirian P. Silva.

77 – RESOURCES USED BY THE SUS WITH RESECTION OF NON – PALPABLE BREAST CODES FROM 2015 TO 2017.
Luís M. M. Medeiros, Mateus F. O. Vilela, Bráulio B. Rodrigues, Isadora G. C. K. Severino, Júlia R. Moraes, Lara C. R. Alvarenga1, Mirian P. Silva.

78 – ANALYSIS OF THE CLINICAL INDICATIONS FOR MAMMOGRAMS IN BRAZIL FROM 2013 TO 2014 BY THE UNIFIED HEALTH SYSTEM.
Diogo T. de Lima, Gabriela F. Araújo, Fábio F. Marques, Guilherme N. Correa, Mateus F. O. Vilela, Bráulio B. Rodrigues, Mirian P. Silva.

79 – THE PREVALENCE OF MALIGNANT AND BENIGN BREAST NEOPLASMS IN BRAZIL BETWEEN 2010 AND 2014.
Fábio F. Marques, Guilherme N. Correa, Mateus F. O. Vilela, Bráulio B. Rodrigues, Diogo T. de Lima, Gabriela F. Araújo, Mirian P. Silva.

80 – HORMONE THERAPY IN TRANSSEXUALS AND THE RISK OF BREAST CANCER.
Gabriela F. Araújo, Fábio F. Marques, Guilherme N. Corrêa, Mateus F. O. Vilela, Bráulio B. Rodrigues, Diogo T. de Lima, Mirian P. Silva.

81 – NEW LABORATORY TESTS FOR DIAGNOSIS AND PROGNOSIS OF BREAST CANCER.
Guilherme N. Corrêa, Mateus F. O. Vilela, Bráulio B. Rodrigues, Diogo T. de Lima, Gabriela F. Araújo, Fábio F. Marques1, Mirian P. Silva.

82 – INCIDENCE AND MORTALITY OF BREAST CANCER IN WOMEN BY AGE GROUP IN BRAZIL AND LATIN AMERICA.
Adila C. S. de Sousa, Carolina B. dos S. Azevedo, Lázaro L. M. de Oliveira, Matheus L. T. Costa, Sarah R. Santos, Thaynara Mercadante.

83 – BREAST PAIN/MASTALGIA DUE TO A FOREIGN BODY IN A PSYCHIATRIC PATIENT: CASE REPORT.
Lucas N. da Silva, Luis F. P. Oliveira, Matheus L. T. Costa, Taynara Mercadante.

84 – SEXUAL BEHAVIOR OF WOMEN WITH BREAST CANCER AND IMPACT ON THE COUPLE’S LIFE.
Mayara M. P. Carvalho1, Ruffo de Freitas Júnior.

85 – BREAST CANCER SCREENING AMONG BRAZILIAN WOMEN: AN INTEGRATIVE REVIEW.
Mônica O. B. Oriá, Camila T. M. Vasconcelos, Marli T. G. Galvão, Aubrey L. Doede, Dan Wilson, Reanna Panagides, Emma M. Mitchell.

86 – MICROINVASIVE CARCINOMA INITTIALY LABELED AS IN SITU.
Ruffo Freitas-Junior, Nayara A. F. Lemos, Nilceana M. A. Freitas, Marise A. R. Moreira, Edésio Martins, José Carlos de Oliveira, Carleane M. B. Silva.

87 – PHOTOBIOMODULATION IN THE SCARATION OF DEISCENCE AFTER MASTECTOMY: CASE REPORT.
Nayara A. F. Lemos, Ruffo Freitas-Junior, Fernanda D. Moraes, Arethuzza A. Moreira, Karla F. Carmo, Alexandre L. Cardoso, Eliceia M. Batista.

88 – ANALYSIS OF THE DETECTION OF MALIGNANT BREAST CANCER LESIONS IN WOMEN IN THE STATE OF GOIÁS IN THE PERIOD 2010-2013.
Paula de O. C. Queiroz, Nayara P. A. Oliveira, Fernando C. R. Pinheiro, Vitória N. Macedo, Hygor A. P. Dutra.

89 – COMPARATIVE ANALYSIS OF THE INCIDENCE AND MORTALITY OF BREAST CANCER IN EUROPE AND LATIN AMERICA AND THE CARIBBEAN IN 2012.
Paula O. C. Queiroz, Larissa S. Valadares, Pedro R. Soares, Luisa R. Barros.

90 – EPIDEMIOLOGICAL ANALYSIS OF THE DISTRIBUTION OF MAMMOGRAPHY PERFORMED IN GOIÁS, MATO GROSSO, MATO GROSSO DO SUL AND FEDERAL DISTRICT FROM 2010 TO 2013.
Paula de O. C. Queiroz, Giselle M. Guimarães, Murilo H. C. e Silva, Isadora R. Silva, Túlio P. A. Basílio, Laine R.Martins.

91 – LIPOFILLING – DIFFERENT TECHNIQUES, SIMILAR RESULTS – EXPERIENCE OF THE ONCOPLASTIC COURSE OF SBM DE JAÚ – SP.
Paulus F. M. Ramos, Maurício de A. Resende, Ailton Joioso, João R. A. Paloschi, Alice J. Pereira.

92 – TATTOO – FORMAL INDICATION OF RADIOISOTOPE USE TO LOCATE SENTINEL LYMPH NODE? REPORT OF TWO CLINICAL CASES.
Paulus F. M. Ramos, Claudia A. A. Góes, Tatiana P. B. B. Figueiredo, Rafael A. M. Hassan, Naiana S. C. Andrade, Rodrigo S. C. Guindalini.

93 – USE OF ASPIRATIONAL PUNCTUATION OF TUMORS WITH FINE NEEDLE (FNAB) FOR THE DIAGNOSIS OF DUCTAL CARCINOMA: ANALYSIS OF CYTOPATHOLOGICAL EXAMINATIONS DONE IN BRAZIL BETWEEN JANUARY 2012 TO JANUARY 2014.
Rafael S. de Lima, Cassiano de S. Coutinho, Fabiana C. Q. S. Anjos, Fernando C. da Silva, Ildelbrando I. A. C. Sobrinho, Priscila F. Barbosa, Rayssa de O. Glória, Vantuir J. D. da Mota.

94 – ANALYSIS OF THE MAIN RADIOLOGICAL FINDINGS OF MAMMOGRAPHIES DONE IN THE BRAZILIAN UNIFIED HEALTH SYSTEM IN THE DISTRITO FEDERAL BETWEEN 2013 AND 2015.
Brenda B. M. Mendes, Higor M. M. Melo, Lindainez A. de Souza, Matheus F. M. Maia, Wglaison P. A. Sobral, Fabiana C. Q. S. Anjos, Rafael S. Lima, Priscila F. Barbosa.

95 – ANALYSIS OF THEIR DELETIONS AND DUPLICATIONS IN THE BRCA1 AND BRCA2 GENES IN PATIENTS FROM GOIÁS-BRAZIL WITH SUSPECTED OF HEREDITARY BREAST AND OVARIAN CANCER SYNDROME.
Rebeca M. Goveia, Paula F. F. Silva, Thais B. Teixeira, Bruno F. Gamba, Aliny P. Lima, Ruffo Freitas-Junior, Elisângela P. Silveira-Lacerda.

96 – A FUNCTIONAL IN VIVO SHRNA SCREEN FOR THE IDENTIFICATION OF TRIPLE-NEGATIVE BREAST CANCER METASTASIS SUPPRESSOR GENES.
Rebeka Tomasin, Ana Carolina Baptista Moreno Martin, Márcia Regina Cominetti, Kaylene Simpson, Robin Anderson, Richard Redvers.

97 – AESTHETIC OUTCOMES AND PATIENTS SATISFACTION AFTER DELAY/IMEDIATE AUTOLOGOUS BREAST RECONSTRUCTION.
Renata S. Brondi, Vilmar M. Oliveira, Fabio Bagnoli, José Francisco Rinaldi, Evandro Mateus Falacci, Fabrício P. Brenelli.

98 – THERAPY OF DIGNITY: STRATEGY FOR THE CONSTRUCTION OF A LEGACY AT THE END OF LIFE.
Natália Novaes Pavani Araújo, Marcella Tardeli Esteves Angelloni Santana, Ricardo Caponero, Joice Aline Klein, Ana Lúcia Coradazzi, Danilo Augusto Mendonça Faleiros.

99 – PROGRAM OF QUALITY CONTROL IN MAMOGRAPHY IN THE STATE OF GOIÁS: EXPERIENCE OF 11 YEARS.
Rosangela da Silveira Corrêa, Ruffo Freitas-Junior, Suzana Alves Bastos, Lucy Aparecida Parreira Marins, Rodrigo Massakatsu Nishiharu Tanaka, Dagoberto Luiz Suzana Costa.

100 – “O TOQUE PELA VIDA”: THE IMPORTANCE OF THE PINK OCTOBER CAMPAIGNS FOR WOMEN HEALTH IN JATAÍ, GO.
Sabrina R. J. Pimenta, Thaynara B. C. Souza, Izabella C. Amaral, Thayanne S. Ramos, Carlos A. L. Silva, Carolina A. E. Terceiro, Bianca D. Vieira, Ana Paula S. Perez.

101 – RETROSPECTIVE COHORT STUDY WITH SURVEY ANALYSIS OF BREAST CANCER SUBMITTED RADIOSURGERY BY CEREBRAL METASTASIS IN 10 YEARS.
Nilceana Maya Aires Freitas, Thais Franco Simionatto, Nathalya Ala Yagi, Jean Teixeira de Paiva, Thais de Toledo Lima Santana, Sebastião Berquó Peleja, Mattheus Humberto do Vale, Silvia Sousa Pires.

102 – THE INFLUENCE OF THE BREAST TUMOR BED CLIPPED IN THE HEART AND LUNG IRRADIATED VOLUME DURING THE BOOST RADIATION PLANNING.
Thaís Franco Simionatto, Nathalya Ala Yagi, Ana Flávia de Paula Guerra Campedelli, Nilceana Maya Aires Freitas, Mattheus Humberto do Vale, Silvia Sousa Pires, Jean Teixeira de Paiva, Carolina Martinelli Bezerril.

103 – PREVALENCE ANALYSIS OF DUCTAL CARCINOMA IN SITU OF BREAT IN WOMEN POPULATION OF GOIÁS BETWEEN 2009-2014.
Lucas N. Silva, Richard R. Santos, Julio M. B. Garcia, Thaynara de M. Pacheco.

104 – ANALYSIS OF THE INCIDENCE OF PRIMARY BREAST CANCER IN RELATION TO THE TOTAL CASES IN THE FEMALE POPULATION OF THE CENTRAL-WEST SCENARIO.
Paula O. C. Queiroz, Nayara P. A. Oliveira, Hygor A. P. Dutra, Thaynara P.

105 – QUANTITATIVE EVOLUTION OF MAMMOGRAPHY IN COUNTIES OF GOIÁS BETWEEN 2010 AND 2013.
Thaynara Mercadante, Guilherme A. Sampaio, Maria L. de Oliveira, Natália S. D. Mendonça, Caio Matheus Fonseca de Brito, Jonatha Fonseca Lopes, Letícia de Souza Cainelli, Pedro Rodrigues Soares.

106 – THE MASTOLOGIST PROFILE IN BRAZIL.
Thaynara Mercadante, Guilherme A. Sampaio, Maria L. de Oliveira, Natália S. D. Mendonça, Caio Matheus Fonseca de Brito, Jonatha Fonseca Lopes, Letícia de Souza Cainelli, Pedro Rodrigues Soares.

107 – NARRATIVE REVIEW ON THE CONSUMPTION OF SOY AND DERIVATIVES RELATED TO THE RISK OF BREAST CANCER.
Fernando C. Ramos, Nayara P. Almeida, Thaynara Mercadante.

108 – DOUBLE MUTATION CARRIER IN BRCA2 AND MUTYH GENES: A CASE REPORT IN A YOUNG BREAST CANCER PATIENT.
Deidimar C.B. Abreu, Leandro G. Oliveira, Pedro P. B. Abreu, Vera A. Saddi.

CONTENTS

See full edition